“Statistics in Biopharmaceutical Research” is the title of the on-line journal launched by the American Statistical Association in 2009. There are at least two other international peer-reviewed journals completely dedicated to the use of statistics to support the development of pharmaceutical products. They are Journal of Biopharmaceutical Statistics (Taylor and Francis Group) and Pharmaceutical Statistics (John Wiley and Sons). There are many books devoted to this area of statistical applications also, e.g., Senn (2008), Dmitrienko et al. (2007) and Dmitrienko et al. (2005). In the United States, pharmaceutical and biotech industries employ thousands of statisticians, either directly or indirectly. These statisticians support the discovery, development and commercialization of valuable medicines, medicines that have made substantial contributions to a longer life expectancy and a better quality of life in the past 50 years.
The development of pharmaceutical products is a long and high...
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References and Further Reading
Almenoff JS, Pattishall EN, Gibbs TG, DuMouchel W, Evans SJ, Yuen N (2007) Novel statistical tools for monitoring the safety of marketed drugs. Clin Pharm Ther 82:157–166
Bornkamp B, Bretz F, Dmitrienko A, Enas G, Gaydos B, Hsu C-H, Konig F, Liu Q, Neuenschwande B, Parke T, Pinheiro J, Roy A, Sax R, Shen F (2007) Innovative approaches for designing and analyzing adaptive dose-ranging Trials. J Biopharm Stat 17: 965–995
Bretz F, Schmidli H, Racine A, Maurer W (2006) Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts. Biometrical J 48(4):623–634
Chuang-Stein C, Bain R, Branson M, Burton C, Hoseyni C, Rockhold F, Ruberg S, Zhang J (2010) Statisticians in the pharmaceutical industry: the 21st century. J Biopharm Stat 2(2):145–152
Declaration of Helsinki, History. Available at http://cme.cancer.gov/c01/a02_02.htm
Dmitrienko A, Molenberghs G, Chuang-Stein C, Offen W (2005) Analysis of clinical trials using SAS: a practical guide. Cary NC, SAS
Dmitrienko A, Chuang-Stein C, D’Agostino R (2007) Pharmaceutical statistics using SAS. SAS, Cary NC, SAS
FDA Guide for Clinical Trial Sponsors – Establishment and Operation of Clinical Trial Data Monitoring Committees, March 27 2006. Available at http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm127073.pdf.
Gallo P, Chuang-Stein C, Dragalin V, Gaydos B, Krams M, Pinheiro J (2006) Adaptive designs in clinical drug development. J Biopharm Stat 16:275–283
Gaydos B, Anderson K, Berry D, Burnham N, Chuang-Stein C, Dudinak J, Fardipour P, Gallo P, Givens S, Lewis R, Maca J, Pinheiro J, Pritchett Y, Krams M (2009) Good practices for adaptive clinical trials in pharmaceutical product development. Drug Inform J 43(5):539–556
International Conference on Harmonisation E6(R1), Guidance for Good Clinical Practice, Step 5, May 1996. Available at http://www.ich.org/LOB/media/MEDIA482.pdf
International Conference on Harmonisation E9, Statistical Principles for Clinical Trials, Step 5, Feb 1998. Available http://www.ich.org/LOB/media/MEDIA485.pdf
International Conference on Harmonisation E10, The Choice of Control and Relatede Issues in Clinical Trials, Step 5, July 2000. Available at http://www.ich.org/LOB/media/MEDIA486.pdf
International Conference on Harmonisation M3(R2): Maintenance of the ICH Guideline on Non-Clinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals, Step 5, June 2009. Available at http://www.ich.org/LOB/media/MEDIA5544.pdf
Krantz JC Jr (1966) New drugs and the Kefauver-Harris amendment. J New Drugs 6:77–79
Masia N (2008) The cost of developing a new drug. In Focus on intellectual property rights. A US Department of State Publication, April 23 2008. Available at http://www.america.gov/st/econ-English/2008/April/20080429230904myleen0.5233981.html
Medical Research Council (1948) Streptomycin treatment of pulmonary tuberculosis. Br Med J 2:769–782
Senn S (2008) Statistical issues in drug development (statistics in practice), 2nd edn. Wiley, New York
Sheiner LB (1997) Learning versus confirming in clinical drug development. Clin Pharm Ther 61:275–291
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Chuang-Stein, C. (2011). Biopharmaceutical Research, Statistics in. In: Lovric, M. (eds) International Encyclopedia of Statistical Science. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04898-2_558
Download citation
DOI: https://doi.org/10.1007/978-3-642-04898-2_558
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-04897-5
Online ISBN: 978-3-642-04898-2
eBook Packages: Mathematics and StatisticsReference Module Computer Science and Engineering